These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 21600147)

  • 21. Efficacy and tolerability of IV doripenem versus meropenem in adults with complicated intra-abdominal infection: a phase III, prospective, multicenter, randomized, double-blind, noninferiority study.
    Lucasti C; Jasovich A; Umeh O; Jiang J; Kaniga K; Friedland I
    Clin Ther; 2008 May; 30(5):868-83. PubMed ID: 18555934
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Microbiology of severe aspiration pneumonia in institutionalized elderly.
    El-Solh AA; Pietrantoni C; Bhat A; Aquilina AT; Okada M; Grover V; Gifford N
    Am J Respir Crit Care Med; 2003 Jun; 167(12):1650-4. PubMed ID: 12689848
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Clinical study of teicoplanin in the treatment of patients with gram-positive cocci: the Chinese experience].
    He LX; Pan J; Chen SY; Wang AX; Xie CM; Shen ZY
    Zhonghua Nei Ke Za Zhi; 2005 May; 44(5):337-41. PubMed ID: 16009001
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of prior effective therapy on the efficacy of daptomycin and ceftriaxone for the treatment of community-acquired pneumonia.
    Pertel PE; Bernardo P; Fogarty C; Matthews P; Northland R; Benvenuto M; Thorne GM; Luperchio SA; Arbeit RD; Alder J
    Clin Infect Dis; 2008 Apr; 46(8):1142-51. PubMed ID: 18444848
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Efficacy and safety of intravenous infusion of doripenem versus imipenem in ventilator-associated pneumonia: a multicenter, randomized study.
    Chastre J; Wunderink R; Prokocimer P; Lee M; Kaniga K; Friedland I
    Crit Care Med; 2008 Apr; 36(4):1089-96. PubMed ID: 18379232
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Methicillin-resistant Staphylococcus aureus prolongs intensive care unit stay in ventilator-associated pneumonia, despite initially appropriate antibiotic therapy.
    Shorr AF; Combes A; Kollef MH; Chastre J
    Crit Care Med; 2006 Mar; 34(3):700-6. PubMed ID: 16505656
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A comparison of cefmetazole, and cefoxitin for the treatment of patients hospitalized with acute urinary tract infections.
    Burke BM; Kessler DL; Cirulli C; Bracken RB
    J Antimicrob Chemother; 1989 Apr; 23 Suppl D():35-8. PubMed ID: 2722722
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Effectiveness of cefmetazole in the treatment of puerperal pyo-septic diseases].
    Zharov EV; Lebed' SV
    Antibiot Khimioter; 1995 Jan; 40(1):41-4. PubMed ID: 7605131
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Clinical efficacy of cefmetazole in intraabdominal infection].
    Hu BS; Liu CY; Wang FD
    Zhonghua Yi Xue Za Zhi (Taipei); 1993 Jun; 51(6):436-9. PubMed ID: 8281491
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Community-Acquired Pneumonia Recovery in the Elderly (CAPRIE): efficacy and safety of moxifloxacin therapy versus that of levofloxacin therapy.
    Anzueto A; Niederman MS; Pearle J; Restrepo MI; Heyder A; Choudhri SH;
    Clin Infect Dis; 2006 Jan; 42(1):73-81. PubMed ID: 16323095
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Therapeutic dilemmas in the treatment of pelvic infections.
    Gall S
    J Reprod Med; 1990 Nov; 35(11 Suppl):1091-4. PubMed ID: 2277378
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Diagnosis and therapy of aspiration pneumonia].
    Ott SR; Lode H
    Dtsch Med Wochenschr; 2006 Mar; 131(12):624-8. PubMed ID: 16544240
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of the efficacy and safety of isepamicin and amikacin in the treatment of acute lower respiratory tract infections caused by gram-negative organisms.
    Covi M; Velluti G
    J Chemother; 1995 Jun; 7 Suppl 2():137-42. PubMed ID: 8622102
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Moxifloxacin-containing triple therapy as second-line treatment for Helicobacter pylori infection: effect of treatment duration and antibiotic resistance on the eradication rate.
    Yoon H; Kim N; Lee BH; Hwang TJ; Lee DH; Park YS; Nam RH; Jung HC; Song IS
    Helicobacter; 2009 Oct; 14(5):77-85. PubMed ID: 19751431
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison of sequential and standard triple-drug regimen for Helicobacter pylori eradication: a 14-day, open-label, randomized, prospective, parallel-arm study in adult patients with nonulcer dyspepsia.
    Uygun A; Kadayifci A; Yesilova Z; Safali M; Ilgan S; Karaeren N
    Clin Ther; 2008 Mar; 30(3):528-34. PubMed ID: 18405790
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Gemifloxacin once daily for 5 days versus 7 days for the treatment of community-acquired pneumonia: a randomized, multicentre, double-blind study.
    File TM; Mandell LA; Tillotson G; Kostov K; Georgiev O
    J Antimicrob Chemother; 2007 Jul; 60(1):112-20. PubMed ID: 17537866
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The efficacy and safety of amoxicillin-clavulanic acid 1000/125mg twice daily extended release (XR) tablet for the treatment of bacterial community-acquired pneumonia in adults.
    Prabhudesai PP; Jain S; Keshvani A; Kulkarni KP
    J Indian Med Assoc; 2011 Feb; 109(2):124-7. PubMed ID: 21888181
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Azithromycin in the treatment of Legionella pneumonia requiring hospitalization.
    Plouffe JF; Breiman RF; Fields BS; Herbert M; Inverso J; Knirsch C; Kolokathis A; Marrie TJ; Nicolle L; Schwartz DB
    Clin Infect Dis; 2003 Dec; 37(11):1475-80. PubMed ID: 14614670
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparison of empiric aztreonam and aminoglycoside regimens in the treatment of serious gram-negative lower respiratory infections.
    Bjornson HS; Ramirez-Ronda C; Saavedra S; Rivera-Vázquez CR; Liu C; Hinthorn DR
    Clin Ther; 1993; 15(1):65-78. PubMed ID: 8458056
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cefepime vs. meropenem for moderate-to-severe pneumonia in patients at risk for aspiration: An open-label, randomized study.
    Oi I; Ito I; Tanabe N; Konishi S; Hamao N; Yasutomo Y; Kadowaki S; Hirai T
    J Infect Chemother; 2020 Feb; 26(2):181-187. PubMed ID: 31473111
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.